Neurosciences

Title
ASPIRE Study
Trial Number
204291
Number of Participants
350
Principal Investigator

David J. Wilber

M.D., FAHA, FACC
Cardiology
George M. Eisenberg Professor of Cardiovascular Sciences
Eligibility

Ventricular tachycardia, drug refractory (including beta-blockers), ICD implanted, history of MI

Purpose

The purpose of this study is to determine if early ablation and medical therapy is more effective than medical therapy alone in treating ventricular tachycardia.

Enrollment

(708) 216-2646

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.